Furthermore, while ezrin is expressed in all breast cancer subtypes, expression was highest in ER+ (Luminal A, Luminal B) and HER2+ subtypes at the RNA level, and the highest in Luminal A and B subtypes at the protein level (Fig. 1C and D). Here, ERBB2 is linked to breast cancer.